Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KARE trial of palifermin for acute lung injury
ISRCTN95690673Phase 2Completed
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Sep 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised trial in acute lung injury (ALI) comparing Palifermin with Placebo (2 arms). Primary endpoint: Oxygenation index at day 7. Started Sep 2010; status: completed.
02
Drugs
palifermin
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on ISRCTN95690673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN95690673.